Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 22, 2015Alimentary Pharmacology & TherapeuticsOpen Access

Systematic review and meta‐analysis: opportunistic infections and malignancies during treatment with anti‐integrin antibodies in inflammatory bowel disease

View Full Paper
Ask AI
Bookmark
Share

Authors

PLPavit LuthraLPLaurent Peyrin‐BirouletAFAlexander C. Ford

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Luthra et al. (2015) studied this question.

synapsesocial.com/papers/6a7bfcf5a540d02696c2b59chttps://doi.org/10.1111/apt.13215
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases2014 · 64 citations
  2. 2Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease2013 · 2,735 citations
  3. 3Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed2014 · 717 citations